However, there is some evidence to suggest that low expression of TYMS and EGFR is associated with increased tumor regression rates [87,88,89,90,91] and low p21 expression may be associated with improved survival in rectal cancer [92] (Table 2). The gene discussed is EGFR; the disease is neoplasm.